Langley, Joanne M <br/><br/>
Immunogenicity of heterologous H5N1 influenza booster vaccination 6 or 18 months after primary vaccination in adults: a randomized controlled clinical trial.  [electronic resource] 

 -  Vaccine  Jan 2015 
 - 559-67 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1873-2518 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2014.11.018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Animals<br/>Antibodies, Neutralizing--blood<br/>Antibodies, Viral--blood<br/>Drug Combinations<br/>Female<br/>Hemagglutination Inhibition Tests<br/>Humans<br/>Immunization, Secondary--methods<br/>Indonesia<br/>Influenza A Virus, H5N1 Subtype--immunology<br/>Influenza Vaccines--administration & dosage<br/>Influenza, Human--prevention & control<br/>Leukocytes, Mononuclear--immunology<br/>Male<br/>Middle Aged<br/>Neutralization Tests<br/>Placebos--administration & dosage<br/>Polysorbates--administration & dosage<br/>Single-Blind Method<br/>Squalene--administration & dosage<br/>Turkey<br/>Young Adult<br/>alpha-Tocopherol--administration & dosage